Thomas B. Fitzpatrick

Thomas B. Fitzpatrick's AcademicInfluence.com Rankings

Medical

#139

World Rank

#214

Historical Rank

#69

USA Rank

Dermatology

World Rank

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Why Is Thomas B. Fitzpatrick Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas B. Fitzpatrick was an American dermatologist. He was Chairman of the Department of Dermatology at Harvard Medical School and Chief of the Massachusetts General Hospital Dermatology Service from 1959 to 1987. He has been described as "the father of modern academic dermatology" and as "the most influential dermatologist of the last 100 years", in part because he trained so many of the leaders in the field.

(See a Problem?)

Thomas B. Fitzpatrick's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dermatology in general medicine (1971) (4293)
The validity and practicality of sun-reactive skin types I through VI. (1988) (3237)
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. (1974) (1238)
The Validity and Practicality of Sun-Reactive Skin Types I Through VI (1988) (696)
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. (1979) (515)
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. (1977) (481)
Biochemistry of melanin formation. (1950) (478)
Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. (1981) (433)
Cutaneous squamous-cell carcinoma in patients treated with PUVA. (1984) (421)
SUBCELLULAR LOCALIZATION OF MELANIN BIOSYNTHESIS (1963) (377)
Oral methoxsalen photochemotherapy of mycosis fungoides (1976) (306)
In vitro bioassay for the melanocyte stimulating hormone. (1954) (304)
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. (1987) (281)
Mammalian tyrosinase; preparation and properties. (1949) (267)
Racial Differences in the Fate of Melanosomes in Human Epidermis (1969) (262)
Mechanism of depigmentation by hydroquinone. (1974) (256)
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. (1993) (247)
Some aspects of melanin biology: 1950-1975. (1976) (245)
Photochemotherapy for psoriasis with orally administered methoxsalen. (1976) (210)
The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas. (1982) (210)
The melanosome: a distinctive subcellular particle of mammalian melanocytes and the site of melanogenesis. (1961) (209)
The Presently Known Distribution of Furocoumarins (Psoralens) in Plants (1962) (207)
The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. (1992) (203)
Oral psoralen photochemotherapy of atopic eczema (1978) (199)
Sun exposure habits in patients with cutaneous melanoma: a case control study. (1983) (193)
Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. (1976) (181)
Chemical Composition and Terminology Of Specialized Organelles (Melanosomes and Melanin Granules) in Mammalian Melanocytes (1963) (179)
Tyrosinase in human skin: demonstration of its presence and of its role in human melanin formation. (1950) (178)
Phototesting and dosimetry for photochemotherapy (1977) (173)
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. (1983) (173)
Mammalian tyrosinase; the relationship of copper to enzymatic activity. (1950) (171)
Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. (1970) (168)
Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions (1982) (167)
Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. (1974) (165)
Malignant Melanoma: Prognostic Significance of “Microscopic Satellites” in the Reticular Dermis and Subcutaneous Fat (1981) (162)
Clinical and Experimental Studies with 8-Methoxypsoralen in Vitiligo1 (1953) (159)
Beta Carotene Therapy for Erythropoietic Protoporphyria and Other Photosensitivity Diseases (1977) (159)
A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. (1972) (157)
Alteration of racial differences in melanosome distribution in human epidermis after exposure to ultraviolet light. (1972) (156)
Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis (1982) (155)
Adjuvant therapy for melanoma. (1983) (149)
The evolution of concepts of melanin biology. (1967) (147)
Usefulness of retinoic acid in the treatment of melasma. (1986) (144)
Inhibition of melanin formation by chemical agents. (1952) (144)
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. (1991) (144)
Dermatology in general medicine : textbook and atlas (1979) (143)
Localization of melanin pigmentation in the skin with Wood's lamp (1977) (140)
Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. (2004) (139)
Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds. (1968) (138)
Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. (1975) (137)
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness (1984) (134)
Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. (1962) (134)
Melanotic macules in Albright's syndrome and in neurofibromatosis. (1968) (131)
Lentigo maligna melanoma has no better prognosis than other types of melanoma. (1984) (128)
Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. (1966) (126)
Topical use of hydroquinone as a depigmenting agent. (1965) (124)
Narrower margins for clinical stage I malignant melanoma. (1982) (120)
Vitiligo and Other Hypomelanoses of Hair and Skin (1983) (120)
Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes (1981) (120)
Ultraviolet-induced pigmentary changes: benefits and hazards. (1986) (117)
Part IV: Basic Considerations of the Psoralens: Historical Aspects of Methoxsalen and Other Furocoumarins1 (1959) (115)
Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen‐induced phototoxic reactions as well as depletion of Langerhans cells in human skin (1997) (115)
Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. (2004) (114)
The natural break points for primary-tumor thickness in clinical Stage I melanoma. (1981) (113)
A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease (1981) (112)
Mitotic activity in non-neoplastic melanocytes in vivo as determined by histochemical, autoradiographic, and electron microscope studies (1975) (111)
Photochemotherapy of Skin Diseases (1982) (110)
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. (1982) (108)
Human melanogenesis; cytology and histology of pigment cells (melanodendrocytes). (1952) (108)
Monobenzylether of hydroquinone (1977) (107)
White leaf-shaped macules. Earliest visible sign of tuberous sclerosis. (1968) (107)
Year Book of Dermatology (1971) (106)
Sunlight and Melanin Pigmentation (1976) (106)
Combined methotrexate-PUVA therapy in the treatment of psoriasis. (1982) (101)
Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. (1973) (99)
A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. (1968) (98)
Early detection of primary cutaneous malignant melanoma. A color atlas. (1973) (98)
Part III: General Considerations of Skin Pigmentation: The Melanocyte: Cytology and Cytochemistry1 (1959) (98)
Ocular and dermal melanocytosis. (1956) (92)
[THE EPIDERMAL MELANIN UNIT SYSTEM]. (1963) (90)
Color Atlas and Synopsis of Clinical Dermatology (2012) (89)
Color atlas and synopsis of clinical dermatology : common and serious diseases (1992) (89)
Evaluation of topical agents that prevent sunburn--superiority of para-aminobenzoic acid and its ester in ethyl alcohol. (1969) (87)
Early recognition of cutaneous melanoma. (1979) (86)
Abnormal reactions of man to light. (1963) (83)
On the nature of the pigment in retinal pigment epithelium. (1957) (82)
Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis (1978) (82)
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. (1981) (82)
The reciprocal relationship between melanization and tyrosinase activity in melanosomes (melanin granules). (1961) (81)
Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin. (1981) (81)
Clinical characteristics of early cutaneous melanoma (1980) (79)
Augmented pigmentation and other responses of normal human skin to solar radiation following oral adminstration of 8-methoxypsoralen. (1955) (77)
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. (1981) (75)
Melanoma risk in individuals with clinically atypical nevi. (1994) (73)
Role of light in human skin color viariation. (1975) (73)
Comparison of PUVA and beta‐carotene in the treatment of polymorphous light eruption (1979) (71)
Terminology of vertebrate melanin-containing cells: 1965. (1966) (70)
CHAPTER 13 – The Nature of Hair Pigment1 (1958) (70)
Tyrosinase Activity in Vertebrate Melanocytes (1959) (70)
Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study. (1983) (69)
Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. (1986) (69)
Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. (1983) (68)
Mechanisms of phototherapy of vitiligo. (1997) (68)
Biology of normal and abnormal melanocytes (1971) (68)
Changes in distribution pattern of cytoplasmic filaments in human melanocytes during ultraviolet-mediated melanin pigmentation. The role of the 100-Angstrom filaments in the elongation of melanocytic dendrites and in the movement and transfer of melanosomes (1975) (66)
Sodium retention and edema from percutaneous absorption of fludrocortisone acetate. (1955) (64)
Accuracy of dermatologic diagnosis by television. (1972) (63)
Part IV: Basic Considerations of the Psoralens: Relationship of Molecular Configuration to the Activity of Furocoumarins Which Increase the Cutaneous Responses Following Long Wave Ultraviolet Radiation1 (1959) (63)
ELECTRON MICROSCOPY OF MELANOCYTES IN HUMAN PIEBALDISM. (1965) (62)
Bioassay of natural and synthetic furocoumarins (psoralens). (1959) (62)
Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo. (1984) (62)
Ultrastructural investigation of autophagocytosis of melanosomes and programmed death of melanocytes in White Leghorn feathers: a study of morphogenetic events leading to hypomelanosis. (1974) (60)
Melanin Formation in Human Skin Induced by Long-Wave Ultra-Violet and Visible Light (1962) (59)
Primary melanoma of the skin: recognition and management. (1980) (59)
Competitive Inhibition of Mammalian Tyrosinase by Phenylalanine and its Relationship to Hair Pigmentation in Phenylketonuria (1957) (59)
HUMAN MELANOGENESIS: The Tyrosinase Reaction in Pigment Cell Neoplasms, with Particular Reference to the Malignant Melanoma: Preliminary Report (1952) (57)
Early detection of malignant melanoma (1976) (57)
Tar photoxicity and phototherapy for psoriasis. (1975) (57)
Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients (1982) (56)
Ocular findings in patients treated with PUVA. (1985) (56)
Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases. (1983) (56)
Ultra-Violet Carcinogenesis in Albino and Pigmented Mice Receiving Furocoumarins: Psoralen and 8-Methoxypsoralen (1959) (56)
Conservative surgical management of superficially invasive cutaneous melanoma (1984) (54)
Sunlight and skin cancer. (1985) (54)
Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles (1978) (52)
Pathogenesis of Generalized Dermal Pigmentation Secondary to Malignant Melanoma and Melanuria (1954) (51)
Mammalian tyrosinase; action on substances structurally related to tyrosine. (1951) (50)
Melanin Granules and Mitochondria (1960) (49)
The nature and origin of the melanin macroglobule. (1984) (49)
Historical aspects of methoxsalen and other furocoumarins. (1959) (48)
Clinical and experimental studies with 8-methoxypsoralen in vitiligo. (1953) (48)
Phototoxic reactions to photoactive drugs in patients treated with PUVA. (1980) (46)
UV-A1 for keloid. (1999) (45)
The melanocyte: cytology and cytochemistry. (1959) (45)
Characterization of a new melanosomal structural component--the vesiculoglobular body--by conventional transmission, high-voltage, and scanning electron microscopy. (1974) (45)
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. (1983) (44)
A comparison of the melanocyte response to narrow band UVA and UVB exposure in vivo. (1987) (43)
Relationship of molecular configuration to the activity of furocoumarins which increase the cutaneous responses following long wave ultraviolet radiation. (1959) (43)
The benefits and risks of long-term PUVA photochemotherapy. (1998) (43)
Demonstration of tyrosinase in melanocytes of the human hair matrix by autoradiography. (1955) (43)
Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. (1985) (42)
Update--dermatology in general medicine (1983) (42)
The Control of Melanogenesis in Human Pigment Cells (1953) (42)
Selective action of mercaptoethylamines on melanocytes in mammalian skin: experimental depigmentation. (1968) (42)
Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. (1984) (42)
Effect of ultraviolet on the distribution pattern of microfilaments and microtubules and on the nucleus in human melanocytes. (1973) (39)
PIGMENT AND PIGMENT TUMORS: BIOCHEMICAL BASIS OF HUMAN MELANIN PIGMENTATION (1954) (38)
Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines: a comparative ultrastructural investigation of lentigines induced by PUVA and sunlight. (1984) (37)
Experimental pigment donation in vivo. (1974) (37)
History and Significance of White Macules, Earliest Visible Sign of Tuberous Sclerosis (1991) (37)
A histochemical autoradiographic method for demonstration of tyrosinase in human melanocytes, nevi and malignant melanoma. (1956) (36)
A genetic and statistical study of psoriasis. (1951) (35)
Effect of BANS location on the prognosis of clinical stage I melanoma: new data and meta‐analysis (1988) (35)
On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma (1979) (33)
Cigarette smoking and malignant melanoma. Prognostic implications (1984) (33)
Prolonged ultraviolet light-induced erythema and the cutaneous carcinoma phenotype. (1976) (33)
Melanin: its role in human photoprotection : a Melanin Symposium held on March 11 and 12, 1994, in Washington, D.C. (1995) (32)
Part V: Clinical Applications of Psoralens, and Related Materials: Increased Erythema Threshold Six Weeks after a Single Exposure to Sunlight Plus Oral Methoxsalen1 (1959) (32)
Oral methoxsalen photochemotherapy (PUVA) of dyshidrotic eczema. (1981) (31)
Formation, Chemical Composition and Function of Melanin Pigments (1986) (31)
QUANTITATIVE DETERMINATION OF DOPA; ITS APPLICATION TO MEASUREMENT OF DOPA IN URINE AND IN THE ASSAY OF TYROSINASE IN SERUM. (1964) (31)
Dimple sign to differentiate benign from malignant pigmented cutaneous lesions. (1977) (31)
Phlebotomy and iron-overload in porphyria cutanea tarda. (1969) (30)
Early death from clinical stage I melanoma. (1983) (30)
Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation (1988) (29)
Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. (1988) (28)
Treatment of melanin hyperpigmentation. (1953) (28)
Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. Dramatic improvement with hyperthermia therapy. (1994) (28)
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. (1983) (27)
Psoralens in photochemotherapy of skin diseases. (1981) (27)
Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis. (1979) (27)
Reducing Mortality and Morbidity of Cutaneous Melanoma: A Six Year Plan: B) Identifying High and Low Risk Pigmented Lesions Using Epiluminescence Microscopy (1994) (26)
Biology and diseases of dermal pigmentation (1981) (26)
Risks and benefits from high-intensity ultraviolet A sources used for cosmetic purposes (1985) (25)
An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent. (1985) (24)
Topical and Systemic Approaches to Protection of Human Skin against Harmful Effects of Solar Radiation (1982) (23)
Prevention of melanoma by recognition of its precursors. (1985) (23)
Part V: Clinical Applications of Psoralens, and Related Materials: Field Trials of the Suntan Promoting Effects of Methoxsalen1 (1959) (23)
Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. (1984) (23)
Decrease in human hair color and feather pigment of fowl following chloroquine diphosphate. (1959) (23)
Phototesting as an objective measure of improvement in erythropoietic protoporphyria. (1979) (22)
Detection of “thin” primary melanomas (1983) (22)
Photochemotherapy of psoriasis. (1984) (22)
Terminology of pigment cells. (1953) (22)
Increased erythema threshold six weeks after a single exposure to sunlight plus oral methoxsalen. (1959) (22)
Oral methoxsalen photochemotherapy of uncommon photodermatoses. (1979) (22)
Large Amounts of Deoxyphenylalanine in the Hydrolysate of Melanosomes from Harding–Passey Mouse Melanoma (1966) (22)
A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet. (1984) (22)
Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study. (1977) (21)
Human skin color: Origin, variation and significance (1985) (21)
Prevention of unintentional overexposure in topical psoralen treatment of vitiligo. (1971) (19)
Effect of methoxsalen on liver function. (1958) (19)
Actinic degeneration in association with long-term use of PUVA. (1985) (19)
Photochemotherapeutic, Photobiological, and Photochemical Properties of Psoralens (1977) (18)
Skin markings in the diagnosis and prognosis of cutaneous melanoma. (1984) (18)
MSH: the melanocyte-stimulating hormone. (1954) (17)
Early recognition of primary cutaneous melanoma. (1982) (17)
Circumscribed Dermal Melaninoses: Classification, Light, Histochemical, and Electron Microscopic Studies on Three Patients with the Erythema Dyschromicum Perstans Type (1982) (16)
Protection of skin from germicidal ultraviolet radiation in the operating room by topical chemicals. (1971) (16)
[Photochemotherapy of psoriasis]. (1976) (16)
Principles of photoprotection in sunburn and suntanning, and topical and systemic photoprotection in health and diseases. (1985) (15)
Occurrence of Tyrosinase in Horse and Fish Melanomas (1950) (15)
Oral Methoxsalen Photochemotherapy of Psoriasis and Mycosis Fungoides (1980) (15)
Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastases. (1982) (15)
Melanoma fact sheet (1979) (15)
Cutaneous Carcinogenic Effects of Sunlight in Humans (1977) (15)
Variegate porphyria in New England. (1982) (15)
Mammalian tyrosinase; melanin formation by ultraviolet irradiation. (1949) (14)
Part IV: Basic Considerations of the Psoralens: Studies of Liver Function in Subjects Receiving Methoxsalen1 (1959) (14)
The Site of Biosynthesis of Mammalian Tyrosinase1 (1961) (14)
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. (1982) (14)
Hypomelanosis (1964) (14)
Candidiasis, vitiligo, Addison's disease, and hypoparathyroidism. (1970) (13)
Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. (1989) (13)
The Skin Cancer Cascade: From Ozone Depletion to Melanoma (1996) (13)
Facial Irritation Due to Sunscreen Products (1975) (13)
Diffuse melanosis secondary to metastatic malignant melanoma. Light and electron microscopic findings. (1981) (13)
On the mechanism of melanin pigmentation in endocrine disorders. (1953) (12)
Topical application of a new derivative of triamcinolone in the treatment of skin diseases. (1958) (11)
Biochemical basis of human melanin pigmentation. (1954) (11)
Acid phosphatase in melanosome formation: a cytochemical study in normal human melanocytes. (1984) (11)
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. (1983) (10)
Color Atlas and Synopsis of Pigmented Lesions (1995) (10)
Iritis in patients with cutaneous melanoma and vitiligo. (1978) (10)
Dominant oculo‐cutaneous albinism (1974) (9)
Topical and Systemic Approaches to Photoprotection (1971) (9)
Sunlight and man: Normal and abnormal photobiologic responses : [proceedings of the International Conference on Photosensitization and Photoprotection, Tokyo, Japan, November 6-8, 1972] (1974) (9)
Topical protection against germicidal radiation. (1972) (9)
Mammalian melanin biosynthesis. (1965) (9)
Multiple hemangiopericytomas; their distinction from glomangiomas (glomus tumors). (1957) (9)
Skin cancer after PUVA treatment for psoriasis. (1979) (9)
Leukoderma Acquisitum Centrifugum: Halo Nevus and Other Hypomelanoses Associated with Neoplasms (1983) (9)
Dermatologic differential diagnosis (1962) (8)
Follow-up-study effect of oral methoxsalen (8-methoxypsoralen) on sunburn and suntan. (1960) (8)
Albinism: some thoughts on the color problem and integration of dermatology and medicine. (1960) (8)
Effect of methoxsalen photochemotherapy on cost of treatment for psoriasis. An example of technological assessment. (1981) (8)
Cutaneous leiomyoma; classification and report of solitary angioleiomyoma. (1956) (8)
Melanogenesis of retinal pigment epithelium of chick embryo. (1981) (8)
Poikiloderma vasculare atrophicans; report of a case with observations at autopsy. (1947) (8)
Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma (2005) (7)
Research and development of oral psoralen and longwave radiation photochemotherapy: 2000 B.C.-1982 A.D. (1984) (7)
Pathophysiology of Hypermelanoses (1995) (7)
Beta‐carotene treatment of erythropoietic protoporphyria (1979) (7)
Diagnosis and management of malignant melanoma. (1986) (7)
Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol. (1975) (7)
Effects of oral methoxsalen (8-methoxypsoralen) on sunburn and suntan; a blind clinical trial. (1958) (6)
Oral methoxsalen photochemotherapy for acne vulgaris. (1978) (6)
Melanin synthesis pathways in the pathogenesis of neurofibromatosis. (1981) (6)
Dermatology In General Medicine: Textbook and Atlas (2nd ed.). Edited by Drs. T. B. Fitzpat-rick, Klaus Wolff, Arthur Z. Eisen, Irwin M. Freedberg, and Frank Austen. New York, McGrawHill. 1979. 1824pp. (8'/2 X 11), 1227 illustrations, $85.00 (1979) (6)
Prognosis in malignant melanoma. (1980) (6)
Some Recent Studies on the Subcellular Unit of Melanin Biosynthesis, the Melanosome (1966) (6)
Skin Color and the Melanin Pigmentary System (1983) (5)
The presenhpy known fistrixuhion of furocoumarins (psoralens) in plants. (1962) (5)
Clinical dermatology (third of three parts). (1973) (5)
On the mechanism of melanin formation by the action of ultraviolet radiation. (1949) (5)
CHEMICAL BINDING OF PROTECTIVE AGENTS TO THE HUMAN STRATUM CORNEUM. (1968) (5)
The site of biosynthesis of mammalian tyrosinase. (1961) (5)
Approach to the Problem of Leukoderma (1983) (5)
Discussion of a case of vitiligo (1999) (5)
Reducing Mortality and Morbidity of Cutaneous Melanoma: A Six Year Plan: A) Identifying the Population at Risk (1994) (5)
Hypomelanosis Secondary to Irradiation and Physical Trauma (1983) (4)
Reversible Inhibition of Growth of Microsporum audouini with Neopyrithiamine.∗ (1951) (4)
Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death. (1984) (4)
Studies of liver function in subjects receiving methoxsalen. (1959) (4)
[Tyrosinase in normal and diseased pigment cells of the skin; detection by histochemical and biochemical method]. (1954) (4)
Modifications of PUVA. (1995) (4)
Diagnosis and Treatment of Common Skin Diseases (1989) (4)
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. 1977. (1989) (3)
Clinical Diagnosis of von Recklinghausen's Neurofibromatosis (1986) (3)
Dermatology 1945–95: The Golden Age of Treatment (1996) (3)
Diagnosis of neurofibromatosis by cutaneous examination. (1992) (3)
Part V: Clinical Applications of Psoralens, and Related Materials: Hair Pigment and Methoxsalen11From the Division of Dermatology, University of Oregon Medical School, Portland, Oregon. (1959) (3)
A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models* (1982) (3)
Total body heliotherapy (1997) (3)
A further note on the genetics of psoriasis. (1952) (2)
Basic Considerations of the Psoralens HISTORICAL ASPECTS OF METHOXSALEN AND OTHER FUROCOUMARINS* (2011) (2)
Problems in diagnosing neurofibromatosis. (1981) (2)
THE BENEFITS AND RISKS OF PHOTOCHEMOTHERAPY LONG-TERM PUVA (1998) (2)
Melanin Biosynthesis in Melanomas (1968) (2)
Chromatophores and Color Change. The Comparative Physiology of Animal Pigmentation.Joseph T. Bagnara , Mac E. Hadley (1974) (2)
Melanin pigmentation. (1961) (2)
[On the role of tyrosinase in mammalian melanogenesis]. (1959) (2)
Evolution of diagnostic accuracy of primary cutaneous malignant melanoma. I. Clinical criteria: 5 (1993) (2)
Hypomelanosis Associated with Inflammation (1983) (2)
Epidermal Melanin Unit (1968) (2)
Field trials of the suntan promoting effects of methoxsalen. (1959) (2)
Presidential address for the Dermatology Foundation. (1973) (1)
Mechanism of pigmentation in Addison's disease (1954) (1)
Hair pigment and methoxsalen. (1959) (1)
Erythema in the primary lesion of superficial spreading melanoma is not of prognostic importance (1982) (1)
Dermatologic Diagnoses in the Intensive Care Unit (1986) (1)
Clinical dermatology. 2. (1973) (1)
SUBCELLULAR LOCALIZATION OF MELANIN BIOSYNTHESTS (1963) (1)
Hypomelanosis Associated with Endocrine Disorders (1983) (1)
The “Missing Link” in the Chain of Discovery of Early Melanoma of the Skin (2001) (1)
Melanoma screening with digital epiluminescence microscopy: 299 (1993) (1)
Fixed drug eruption (phenacetin). (1965) (1)
Enzymatic oxidation of tyrosine and dihydroxyphenylalanine by melanoma extracts. (1948) (1)
Ultrastructure study on the alteration in the keratinocytes after TMP application and UV exposure. (1973) (1)
Clinical dermatology. 1. (1973) (0)
Figure 119.28, [Cowden’s disease. Translucent keratotic papules...]. (2000) (0)
Diffuse generalized epidermal hypermelanosis (1986) (0)
[Photosensitization caused by drugs]. (1973) (0)
Separation of mitochondria and melanosomes of cloudman s-91 melanoma. Abstr. (1965) (0)
THE TRENDS AND FUTURE OF PHOTOBIOLOGY MEDICAL ASPECTS (1982) (0)
Points from Letters: Talent and the Individual (1966) (0)
Special Travel Grants in Dermatology Available (1957) (0)
Advances in Biology of Skin. Volume 8 (1968) (0)
Comparison of tyrosinase activity in normal and neoplastic human pigment cells using radioactive tyrosine (1954) (0)
Effects of Depigmenting Agents on Melanocytes and Melanogenesis (1968) (0)
Erythropoietic protoporphyria. (1969) (0)
Further studies demonstrating an increased erythemal threshold following oral methoxsalen. (1960) (0)
Techniques for Examination of the Skin (A Brief Course in Dermatology) (1977) (0)
Report on United States--Japan Cooperative Cancer Research Program: melanoma and skin cancer--biology and comparative features in the United States and Japan. (1989) (0)
Remarks From Thomas B. Fitzpatrick, MD, First President, International Pigment Cell Society (1987) (0)
Skin Markings in Melanoma (1985) (0)
Melanoma: Clinical and Therapeutic Aspects (1988) (0)
Letter: Facial irritation due to sunscreen products. (1975) (0)
Professor Makoto Seiji (1983) (0)
A case for diagnosis (dermatopathia pigmentosa reticulosis?). (1965) (0)
Cost-effectiveness of PUVA Therapy: Further Considerations-Reply (1982) (0)
Furocoumarines for photochemotherapy of psoriasis and other skin diseases that are sensitive to it (1980) (0)
[Electron microscopic observations of hair-matrix melanosomes--morphological differences due to hair color]. (1984) (0)
The biology of pigmentation. (1971) (0)
Hypomelanoses Associated with Nutritional and Metabolic Disorders (1983) (0)
Thomas B. Fitzpatrick (2004) (0)
Skin phototype and melanoma: 34 (1993) (0)
Curriculum vitae: Thomas bernard fitzpatrick. (1983) (0)
Infectious and Parasitic Hypomelanosis (1983) (0)
Early death from clinical stage I melanoma. (1983) (0)
Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. (1970) (0)
Phototherapy and Photochemotherapy of Psoriasis (1991) (0)
Melanoma: Clinical and Therapeutic Aspects (1988) (0)
Furocoumarin for the photochemistry of psoriasis and other skin diseases that are sensitive (1980) (0)
A plea to help build the future of dermatology. (1982) (0)
Beta-carotene treatment of erythropoietic protoporphyri. (1979) (0)
Oral polypodium leucotomos extract protects against ultraviolet induced damage to human skin (2004) (0)
THE PRESENTLY KNOWN DISTRIBUTION OF FUROCOUMARINS (2010) (0)
[Dysplastic melanocytic nevi: quantitative ultrastructural investigation comparing intraepidermal melanocytes of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and normal skin]. (1988) (0)
Photosensitivity caused by drugs. (1972) (0)
Multiple melanocytoma. (1970) (0)
PROF. MAKOTO SEIJI MEMORIAL LECTURE (1983) (0)
Leukodermas without Hypomelanosis (1983) (0)
Erythropoietic protoporphyria. (1965) (0)
Melanin pigmentation. (1961) (0)
Polypodium extractor as photoresist. (1996) (0)
Melanins and Melanogenesis (1995) (0)
[Detection of tyrosinase in normal and diseased pigment cells of the skin by means of radioactive tyrosine; original slide method; its applications in diagnosis of malignant melanoma]. (1954) (0)
Zinc and melanin formation. Abstr. (1962) (0)
Progress in the Biological Sciences in Relation to Dermatology (1959) (0)
Proceedings and Transactions (1987) (0)
Pigments in Pathology. Moshe Wolman, Ed. Academic Press, New York, 1969. xviii, 554 pp., illus. $29.50 (1970) (0)

This paper list is powered by the following services:

Other Resources About Thomas B. Fitzpatrick

en.wikipedia.org

What Schools Are Affiliated With Thomas B. Fitzpatrick?

Thomas B. Fitzpatrick is affiliated with the following schools: